Skip to main content

Market Overview

Recap: Quotient Q3 Earnings



Shares of Quotient (NASDAQ:QTNT) moved higher by 1.2% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 21.62% year over year to ($0.29), which were in line with the estimate of ($0.29).

Revenue of $8,751,000 up by 10.20% from the same period last year, which beat the estimate of $8,300,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

Quotient hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Feb 01, 2021

Time: 08:00 AM

ET Webcast URL:


52-week high: $10.38

Company's 52-week low was at $2.40

Price action over last quarter: Up 13.52%

Company Description

Quotient Ltd is a commercial-stage diagnostics company. It is involved in the business of provision of tests with an initial focus on blood grouping and serological disease screening. The company develops and commercializes Mosaiq automation platform. Its product portfolio includes Red cell reagents, Antisera, Specialty products, Specialty kits etc. The firm operates in Edinburgh, Scotland, Eysins, Switzerland and Newton, Pennsylvania. It derives the majority of its revenue from the United States.


Related Articles (QTNT)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at